Gillett, Sarah R. and Jordan-Bruno, Ximena and Rehman, Hibba and Thomas, Alissa A. 'Immune-Brain': A Retrospective Review of Cognitive Dysfunction/Decline in Cancer Patients on Checkpoint Inhibitors , SSRN: 2025
Xin Wang, Phyllis A. Gimotty, Andrew H. Matthews, Ronac Mamtani, Selina M. Luger, Elizabeth O. Hexner, Daria V. Babushok, Shannon R. McCurdy, Noelle V. Frey, Ximena Jordan Bruno, Saar Gill, Mary Ellen Martin, Vikram R. Paralkar, Ivan Maillard, David L. Porter, Alison W. Loren, Alexander E. Perl, Keith W. Pratz, Kelly D. Getz, Catherine Lai Evolving racial/ethnic disparities in AML survival in the novel therapy era
, Blood Adv (2025) 9 (3): 533–544.: 2025
hannon R. McCurdy, Anthony D Sung, Rebecca T. Brown, Marni Kessler, Nelson J. Chao, Thuy T. Koll, Alfred Fisher, Ernaya Johnson, Meagan Lew, Lauren Bohannon, Sanghee Hong, Pashna Munshi, Saar I. Gill, Nasheed M. Hossain, Sarah Skuli, Noelle V. Frey, Elizabeth O Hexner, Ximena Jordan Bruno, Daria Babushock, Catherine E. Lai, Mary Ellen Martin, Selina M. Luger, David L Porter, Alison W. Loren, Vijaya Raj Bhatt, Phyllis Gimotty Machine Learning Models Demonstrate Gait Speed As the Best Predictor of Survival and Relapse-Free Survival in Older Adults Undergoing Allogeneic Hematopoietic Cell Transplantation , Transplantation and Cellular Therapy: 2025
Ashley D. Hadjis, Honghong Sun, Yangzhu Du, Rebecca T. Brown, Pashna Munshi, Saar I. Gill, Nasheed M. Hossain, Sarah Skuli, Noelle V. Frey, Elizabeth O Hexner, Ximena Jordan Bruno, Catherine E. Lai, Mary Ellen Martin, Selina M. Luger, David L Porter, Alison W. Loren, Shannon R. McCurdy Graft-Versus-Host Disease (GVHD) and Senescence-Associated Biomarkers Correlate with Frailty and Survival in Older Adults Undergoing Hematopoietic Cell Transplantation (HCT) , Transplantation and Cellular Therapy: 2025
Rowe M, Babushok D, Carroll M, Carulli A, Frey N, Gill S, Hexner E, Hirsh R, Hossain N, Lai C, Loren A, Luger S, Maillard I, McCurdy S, Matthews A, Martin ME, Paralkar VR, Perl A, Porter D, Pratz K, Stadtmauer E, Bruno XJ. Tumor Lysis Syndrome in Acute Myeloid Leukemia Patients Treated With a Venetoclax Based Regimen , Eur J Haematol: 2025
Ana I. Velazquez, Carolina Bernabe-Ramirez, Idalid Franco, Cristiane Decat Bergerot, Lauren Kiel, Ximena Jordan Bruno & Narjust Florez Hispanic/Latinx Representation in the US Physician Workforce
, In book: Physician Workforce Diversity: 2024
Matthew P. Connor
Neeharika Prathapa
Noelle V. Frey
Saar I. Gill
Elizabeth O. Hexner
Ximena Jordan Bruno
Catherine E. Lai
Alison W. Loren
Selina M. Luger
Andrew H. Matthews
Shannon R. McCurdy
Alexander E Perl
David L. Porter
Arlene Zeringue
Joseph H. Oved
Timothy S. Olson
Keith W. Pratz
Daria V. Babushok Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia
April 2024Haematologica
DOI: 10.3324/haematol.2024.285275
LicenseCC BY-NC 4.0 , Haematologica : 2024
Margaret Rowe, Daria V Babushok, Martin Carroll, Alison Carulli, Noelle V. Frey, Saar Gill, Elizabeth O Hexner, Rebecca Hirsh, Nasheed Hossain, Catherine Lai, Alison W Loren, Selina M Luger, MD, Ivan Maillard, Shannon R McCurdy, Andrew H Matthews, Mary Ellen Martin, Vikram R Paralkar, Alexander Perl, David L. Porter, Keith W Pratz, Edward A. Stadtmauer, Ximena Jordan Bruno Comparing Cairo Bishop and Howard Criteria for Identifying Clinically Meaningful Tumor Lysis Syndrome Among Acute Myeloid Leukemia Patients Treated with Venetoclax and Hypomethylating Agents: A Single Center Experience , American Society of Hematology Annual Meeting: 2023
Sindhu Janarthanam Malapati, MD1; Dame Idossa, MD2; Sunny R.K. Singh, MD1; Zihan Wei, MS3; Lauren Kiel, BS3; Fumiko Chino, MD4; Monica Arun Patel, MD5; Ximena Jordan Bruno, MD6; and Narjust Florez, MD3 Parent Penalty: Parental Leave Experiences of Trainees and Early-Career Faculty in Oncology Subspecialties , Journal of Clinical Oncology
, 19(10): 2023,899-906
Andrew H. Matthews, Alexander E. Perl, Selina M. Luger, Saar I. Gill, Catherine Lai, David L. Porter, Sarah Skuli, Ximena Jordan Bruno, Martin P. Carroll, Craig W. Freyer, Alison Carulli, Daria V. Babushok, Noelle V. Frey, Elizabeth O. Hexner, Mary Ellen Martin, Shannon R. McCurdy, Edward A. Stadtmauer, Alison W. Loren, Vikram R. Paralkar, Ivan P. Maillard, Keith W. Pratz Real world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia , American Journal of Hematology, 98(8): 2023,1254-1264
